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Human T-cell leukemia virus type 1 (HTLV-1) 
propagates in CD4 or CD8 T cells and, after extended 
latency periods of 30–50 years, causes a rapidly fatal 
leukemia called adult T-cell leukemia/lymphoma (ATL). 
Infection with HTLV-1 is also associated with a 
degenerative neuromuscular disease referred to as tropical 
spastic paraparesis or HTLV-1-associated myelopathy. 
HTLV genome, in addition to the structural proteins and 
retroviral enzymes, codes for a region at its 3' end 
originally designated pX. The products of this region (Tax, 
Rex, p12I, p13II, p30II and HBZ) play important roles in 
deregulation of cellular functions by either directly 
disrupting cellular factors or altering transcription of viral 
and cellular genes. Here, we will review current knowledge 
of protein-protein interactions that regulate transcriptional 
























Viruses have developed a variety of strategies to 
modulate the host cells transcriptional apparatus with the 
aim of optimizing viral mRNA replication and alteration of 
cellular genes expression.  Retroviruses comprise a distinct 
group of enveloped RNA viruses that replicate by reverse 
transcribing their RNA genomes to form a DNA copy that 
integrates into the host cell genome. The integrated proviral 
DNA is then transcribed by RNA polymerase II (Pol II) to 
produce mRNAs that are translated into viral proteins and 
packaged into assembling core particles in the cytoplasm or 
at the plasma membrane. Retroviruses are obligate parasites 
with small genomes and, thus, are dependent on host factors 
for their replication. Among retroviruses, deltaretroviruses 
are complex viruses that assemble at the plasma membrane 
and contain a central spherical inner core (C-type 
morphology). The most famous member of this group is the 
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Human T-cell leukemia virus type-1 (HTLV-1), the first 
pathogenic retrovirus discovered in humans 28 years ago 
(1). HTLV-1 is the causative agent of two major diseases: a 
rapidly fatal leukemia designated adult T-cell leukemia 
(ATL) (2) and a neurological degenerative disease known 
as tropical spastic paraparesis (TSP) or HTLV-1-associated 
myelopathy (HAM) (3).   
 
The HTLV-1 genome encodes the structural 
proteins necessary to form the viral core particle (Gag and 
Env) and the enzymatic retroviral proteins, (reverse 
transcriptase, integrase and protease). In addition, the 
HTLV-1 genome contains a cluster of at least five open 
reading frames (ORFs) within the pX region that are 
generated by alternative splicing. The tax and rex genes are 
the most extensively studied and encode a phosphoprotein 
of 40 kD, and a protein of 27 or 21 kD proteins, 
respectively. The other pX genes encode p12I, p27I, p13II, 
and p30II (4). A novel ORF has been recently identified in 
the complementary strand of the pX region and encode the 
basic leucine-zipper factor HBZ (5). Most of these proteins 
are implicated in the regulation of viral and cellular genes 
expression. Here, we will review transcriptional and/or 
post-transcriptional regulation by HTLV-1 proteins.  
 
3. REGULATION OF HTLV-1 GENE EXPRESSION 
 
3.1. Interaction of the HTLV-1 LTR with transcription 
factors 
The HTLV-1 long terminal repeat (LTR) is divided 
into three regions: U3, R and U5. The U3 region contains 
elements critical for viral gene expression: the polyadenylation 
signal, TATA box and transcription factors binding sites. The 
21-bp repeats, termed Tax responsive element 1 (TRE1), are 
the first transcription factors-binding sites identified in the 
HTLV-1 LTR. Cellular proteins such as CREB and other bZIP 
family members have been shown to bind TRE1 via a TGACG 
(T/A) (C/G) (T/A) motif that is an imperfect homologue of the 
cAMP-responsive element (CRE; TGACGTCA) (6-7). The 
major protein complexes formed on the TRE1 are CRE-
dependent except the Sp-1 transcription factor, which binds to 
the proximal TRE1 (8). A serum response factor (SRF) 
binding site (CArG box) and a ternary complex factor (TCF) 
binding site CCGGAA) are located within a different region of 
U3 known as Tax responsive element 2 (TRE2) (9) and they 
recruit several transcription factors including Sp-1, TIF-1, c-
Myb, Elk-1 and SRF (10) (Figure 1A).  
 
These cellular proteins control basal transcription 
regulation of the HTLV-1 LTR promoter and they recruit Tax 
to fully activate transcription. Tax does not bind DNA directly 
but rather acts via protein-protein interactions with cellular 
transcription factors bound to the viral LTR promoter. The 
cooperative binding of Tax with several of these transcription 
factors to the HTLV-1 promoter may position Tax to interact 
and influence the basal transcription components such as TBP, 
CBP, TFIIA, TFIID and RNA polymerase II (11-15). 
 
3.2. Interaction of Tax with transcriptional activators  
Several bZIP proteins including CREB (16-18), 
ATF-2 (18), ATF-4 (19-20), and c-Jun (21) interact with 
Tax and can redundantly serve to mediate Tax-activation of 
the LTR. However, a clear preference for CREB has been 
shown (22). Both CREB and Tax associate with the viral 
21-base-pair repeat as dimers (23). The effect of Tax on 
CREB-DNA binding can be explained by a two step 
mechanism where Tax changes the apparent equilibrium 
constants for both a CREB-CREB dimerization and a 
(CREB)2-DNA binding step (24) (Figure 1B). The 
interaction between Tax and CREB results in increased 
binding of the Tax/CREB complexes to the HTLV-1 21-bp 
repeats. Compared with CREB alone, Tax/CREB exhibits 
greatly increased DNA recognition specificity and 
preferentially assembles on the 21-bp repeats. 
Phosphorylation of CREB at serine 133 plays an important 
role in the recruitment of the large cellular coactivator 
CREB-binding protein (CBP)/p300 to the HTLV-1 
promoter (12, 25). Indeed, Tax and the phosphorylated 
kinase inducible domain (pKID) of CREB bind distinct 
surfaces of a compact hydrophobic core, termed KIX 
domain, of CBP/p300 and stabilize the CBP/p300 cofactor 
on the HTLV-1 promoter (26-27). The KIX domain of 
CBP/p300 contributes to Tax transactivation by targeting 
the acetyltransferase activity of the coactivator to the Tax-
CREB (Tax/CREB) complex (28). In addition to 
CBP/p300, the p300/CREB binding protein (CBP)-
associated factor (PCAF) is also involved in transcriptional 
activation by Tax. PCAF interacts directly with Tax, 
independently of p300/CBP. PCAF is then recruited to the 
TREs and cooperates with Tax to activate HTLV-1 
transcription. In contrast of the p300 stimulation, the PCAF 
coactivator activity on Tax transactivation is independent 
of its HAT activity on the viral long terminal repeat (29) 
(Figure 1B).  
 
3.3. Interaction of Tax with transcriptional repressors  
Mammalian cells have evolved a variety of 
mechanisms to impede retroviruses, which are pathogenic 
or mutagenic to their hosts. Viruses potentially exploit 
some of those mechanisms as a strategy for persistence in 
their host cells. HTLV-1 LTR CRE sites can potentially 
bind to a variety of bZIP proteins resulting in diverse 
transcriptional regulatory activities. It has been shown that 
ATFx (also known as ATF5), the sole member of the 
CREB/ATF family of bZIP factors that exhibits an anti 
apoptotic activity (30), inhibits basal and Tax-dependent 
transcriptional activation by bridging interaction between 
Tax and the TRE1 (31). The CCAAT/enhancer binding 
protein beta (C/EBPbeta), another bZIP protein, is able to 
form stable heterodimers with CREB and repress Tax 
transactivation function by competing with the ability of 
Tax to bind homo- or heterodimers of CREB/ATF family 
members (32).   
 
Histone deacetylases (HDACs) constitute a 
different group of repressors that could play an important 
role in HTLV-1 silencing in vivo. Histones form the 
backbone of chromatin. HAT enzymes acetylate lysine 
residues on histones, neutralize their positive charges and 
diminish their ability to bind negatively charged DNA. This 
open chromatin configuration provides accessibility to the 
general transcription machinery and regulatory factors. 
Thus, HATs enzymes facilitate transcriptional activation of 
several genes in vivo. On the contrary, HDACs remove 




Figure 1. A. Schematic representation of the HTLV-1 LTR. Binding sites of several proteins, such as CREB, Myb1, Ets1, AP-2, 
Sp-1, TIF-1 are indicated. The three CREB/ATF binding sites (TREI) and the SRF/TCF binding site (TREII) are also indicated. 
B. Schematic illustration of the DNA elements and regulatory factors involved in Tax-induced transcriptional activation of 
HTLV-1 LTR. Tax interacts with CREB/ATF proteins, strengthens their dimerization and their LTR binding to induce HTLV-1 
expression. Moreover, Tax recruits co-activators (such as CBP/p300 and PCAF) and repressors (such as ATFx, C/EBPβ, 
HDAC1, HDAC3, and SUV39H1). 
 
acetyl groups from histones, allowing compacted chromatin 
to reform. HATs and HDACs are not just specific for 
histones. Many regulatory factors of the cell cycle, DNA 
repair, recombination and replication, signaling molecules 
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such as kinases and phosphatases, viral proteins such as 
HIV Tat are also regulated by HATs/HDACs interplay 
(33). In the context of the regulation of HTLV-1 genes 
expression, it has been demonstrated that Tax interacts with 
class I histone deacetylases HDAC-1 and -3 (34-35). 
Interaction of Tax with HDACs negatively regulates Tax 
transactivation function. This repression can be relieved by 
treatment with Trichostatin A, an HDAC inhibitor, or by 
overexpression of the transcriptional activator CBP. 
HDACs are likely to compete with p300/CBP and PCAF in 
binding with Tax and regulating the transcriptional 
activation of the HTLV-1 LTR promoter. Tax also interacts 
with SUV39H1, an histone methyltransferase that 
methylates histone H3 at lysine 9 (H3K9). SUV39H1 
represses Tax transactivation of the LTR in manner 
dependent on the methyltransferase activity of SUV39H1 
(36) (Figure 1B). 
 
Inhibition of Tax transactivation activity also 
occurs by indirect mechanisms. For instance, the 
homeodomain protein MSX2, a general negative regulator 
of gene expression, known to interact with components of 
the basal transcription machinery such as TFIIF (RAP74 
and RAP30) (37) is recruited by Tax and inhibits HTLV-1 
LTR activation (38). We have also shown that HTLV-1 
Tax can be sequestered out of the nucleus by some cellular 
partners such as tristetraprolin (TTP) and G proteins beta 
subunits (39-40). 
 
3.4. Contribution of Rex, p30 and HBZ in regulating 
HTLV-1 expression 
The Rex protein of HTLV-1 has been shown to 
participate in the production of viral particles. Rex binds to 
the cis-acting sequences (Rex response element) present at 
the 3’ end of viral mRNAs (41) and selectively export the 
unspliced gag/pol and env viral mRNA from nucleus to the 
cytoplasm in a CRM1-dependent manner. As a result, Rex 
increases the expression of structural and enzymatic 
proteins and the formation of viral particles (41). In 
contrast with Rex, HTLV-I p30II is a nuclear protein that 
binds to the doubly spliced mRNA encoding Tax and Rex 
proteins, and retains them in the nucleus. Overexpression of 
p30 blocks the translocation of tax/rex mRNA from the 
nucleus to the cytoplasm, resulting in the inhibition of viral 
gene expression and promoting viral latency and 
persistence in vivo (42-43).  
 
The more recently discovered HBZ protein 
encoded by the complementary strand of the HTLV 
proviral genome possesses a putative bZIP domain and is 
able to dimerize with cellular bZIP proteins including 
CREB-2, c-Jun and JunB. Its interaction with CREB-2 and 
AP-1 transcription factors suppresses HTLV-1 basal 
transcription and Tax-transactivation activity (5, 44).  
 
In summary, HTLV-1 has evolved a complex 
regulatory mechanism of antagonizing viral transcriptional 
(Tax versus HBZ) and post-transcriptional (Rex versus 
p30) regulators to allow a control of viral gene expression. 
The interplay between these viral and cellular regulatory 
proteins contributes to multiple steps of the leukemogenesis 
process.  
4. REGULATION OF CELLULAR GENE 
EXPRESSION IN HTLV-1 INFECTED CELLS 
 
The effects of Tax on cellular genes expression have an 
important impact on HTLV-1 induced transformation. In 
fact, Tax modulated genes are involved in crucial cellular 
mechanisms such as apoptosis and proliferation, cell cycle 
and division, cell migration or immune response and 
inflammation. Tax transactivates these cellular promoters 
by interacting with transcription factors such as 
CREB/ATF, NF-κB, SRF and AP-1. 
 
4.1. The CREB/ATF pathway 
In addition to the regulation of viral genes 
expression, the CREB/ATF pathway is also used by 
HTLV-1 to deregulate cellular genes expression. For 
example, the development of ATL has been associated with 
T lymphocytes containing abnormal chromosomal content, 
which develops due to aberrant mitotic divisions. Several 
studies have demonstrated the crucial role of Tax in the 
development of aneuploidy in infected cells. Tax acts 
through protein – protein interactions with cell cycle 
mediators including MAD1/MAD2 (45), Chk1 (46), the 
anaphase promoting complex (APC)- APC-Cdc20 (47) or 
cyclin D-cdk and p110Rb (48). Alteration of cellular genes 
transcription is an additional mechanism used by HTLV-1 
to deregulate cell division. Gene expression profiling and 
bioinformatics promoter analysis identified 95 genes 
containing CREB binding sites and over-expressed in Tax-
expressing cells; 11 of these genes are involved in G2/M 
phase regulation, in particular kinetochore regulation 
including Sgt1 and p97/Vcp (49). Another example is the 
phosphatidylinositol-3-kinase (PI3K) and AKT (protein 
kinase B) signaling pathways that plays an important role 
in regulating cell cycle progression and cell survival. Tax 
activates PI3K/Akt through activating the CREB signaling 
pathway. Activation of PI3K/Akt pathway leads to β-
catenin over-expression in Tax-positive HTLV-1 infected 
cells. β-catenin has been implicated in the malignant 
transformation of cells and probably plays an important 
role in T lymphocytes transformation by HTLV-1 (50). 
 
4.2. NF-κB pathway activation 
In mammalian cells, there are five NF-κB family 
members, RelA (p65), RelB, c-Rel, p50/p105 (NF-κB1) 
and p52/p100 (NF-κB2), organized in different homo and 
heterodimer NF-κB complexes. All NF-κB family members 
share an approximately 300-amino acids N-terminal Rel-
homology domain (RHD), which mediates DNA binding, 
dimerization and nuclear localization. In most cells types, 
NF-κB complexes are retained in the cytoplasm by a family 
of inhibitory proteins known as inhibitors of NF-κB (IκBs). 
There are two principal IκBs, IκBα and IκBβ, which 
function in part by masking a conserved nuclear 
localization sequence (NLS) of the RHD. The classical NF-
κB pathway is induced in response to various stimuli, 
including the pro-inflammatory cytokines tumour necrosis 
factor-alpha (TNFα) and interleukin-1 (IL-1), engagement 
of the T-cell receptor (TCR) or exposure to viral and 
bacterial products. Following induction by various stimuli, 
the IκBs are phosphorylated and degraded by the 
proteasome. Thus activated, NF-κB translocates to the 
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nucleus, where it stimulates transcription of genes 
containing the κB consensus binding site 5-
GGGRNNYYCC-3. The IκB kinase (IKK) complex is 
responsible for IκB phosphorylation. It consists of three 
core subunits, the catalytic subunits IKKα and IKKβ and 
several copies of a regulatory subunit called the NF-κB 
essential modifier (NEMO, also known as IKKγ) (51). In 
normal T cell, NF-κB activation occurs transiently in 
response to immune stimuli required for antigen-stimulated 
T-cell proliferation and survival. T-cell transformation by 
HTLV-1 involves deregulation of cellular transcription 
factors, including members of the NF-κB family.  
 
HTLV-1 Tax acts at different levels to activate 
the NF-κB pathway. (1) IKKγ/NEMO recruits Tax to the 
IKK catalytic subunits IKKα and IKKβ resulting in their 
activation (52-53) (Figure 2A). (2) Tax associates with 
upstream activating kinases MEKK-1 and Tak-1 that 
phosphorylate IKKγ/NEMO (54-55) (Figure 2B). (3) Tax is 
also able to block the activity of the protein phosphatase 2A 
(PP2A), which dephosphorylates IKKγ/NEMO (56). (4) 
Tax can stimulate IKKα and IKKβ kinase activities 
through direct interaction (57). (5) Finally, Tax targets IκB 
to degradation by bridging the interaction between IκB and 
two subunits (HsN3 and HC9) of the 20S proteasome (58-
59) (Figure 2C). Thus, Tax is able to induce a cascade of 
events leading to the nucleo-cytoplasmic translocation of 
the NF-κB subunits. As a result, infection by HTLV-1 
induces a chronically persistent activation of NF-κB, 
causing deregulated expression of a large array of cellular 
genes that govern normal growth-signal transduction, such 
as cytokines and growth factors (IL-2, IL-6, IL-15, TNFα, 
and GM-CSF), cytokine receptors (IL-2 and IL-15 receptor 
α chains), proto-oncogenes (c-Myc), and antiapoptotic 
proteins (Bcl-xL). In particular, upregulation of IL-2 and 
IL-2 receptor α chain expression, as well as IL-15 and IL-
15 receptor α, initiates an autostimulatory polyclonal 
expansion of T cells during the early phase of HTLV-1 
infection. The persistent activation of NF-κB by Tax 
contributes to the initiation and maintenance of the 
malignant phenotype. In transgenic mice expressing Tax, 
elevated levels of NF-κB activity are absolutely required 
for the continued growth of tumor cells in vivo (60).  
 
NF-κB activation also plays a role in the 
inhibition of the tumor suppressor p53. Inactivation of p53, 
through mutations or protein interactions, is common in 
human cancers. It was demonstrated that expression of the 
HTLV-1 Tax protein was sufficient for stabilization and 
transcriptional inactivation of wild-type p53 (61). Tax 
inhibits p53 transcriptional activity through the NF-κB 
signaling pathway, specifically the p65/RelA subunit (62, 
63). Upon NF-κB activation by Tax via IKKβ, p65/RelA 
subunit binds to p53 and inactivates its transcriptional 
functions (64). NF-κB activation thus likely links the 
expression of Tax to T-cell transformation in HTLV-1 
infected cells. 
 
4.2. The SRF pathway 
Tax protein activates the expression of cellular 
immediate early genes controlled by the serum response 
element (SRE), which contains both the serum response 
factor (SRF) binding element (CArG box) and the ternary 
complex factor (TCF) binding element (Ets box) (65). To 
activate this pathway, Tax does not directly bind to the 
CArG box but directly interacts with SRF (66) and TCF 
(67) transcription factors. In addition, Tax interactions with 
CBP/p300 and PCAF are essential for activation of SRF-
mediated transcriptional activation (67) (Figure 3). Dimeric 
transcription factors such as AP-1 and Egr-1 that result 
from the activation of the SRF pathway, are highly 
expressed in HTLV-1 infected T-cells (68), and regulate 
the expression of multiple genes essential for cell 
proliferation, differentiation and prevention of apoptosis. In 
addition to Tax, HTLV-1 HBZ protein also plays a 
regulatory role in the SRF pathway. Indeed, HBZ directly 
binds to c-Jun and JunD AP-1 proteins (69-70) and may 
deregulate the human telomerase catalytic subunit (hTERT) 




HTLV-I was the first human retrovirus 
associated with human disease (1). After transmission of 
HTLV-I, 2–5% of carriers are likely to develop adult T 
cell leukemia (ATL) after a long latent period. The 
molecular mechanisms that govern oncogenesis and 
other pathologies induced by HTLV-1 have been the 
focus of investigations and have allowed dissecting many 
cellular processes. However, the pathogenesis of ATL 
remains completely understood and there are no effective 
therapies for the disease. Because of their limited 
genome size (8,506 bp for HTLV-I), complex 
retroviruses have evolved to use RNA splicing to express 
regulatory genes with pleiotropic actions. Among them, 
Tax is thought to play a central role in leukemogenesis 
through its multiple protein interactions and deregulation 
of cellular pathways. Tax transgenic mice generated 
using the Lck proximal promoter to restrict transgene 
expression to developing thymocytes, developed diffuse 
large-cell lymphomas and leukemia with pathological 
and immunological features characteristic of acute ATL 
(60). This recent study suggested that Tax expression 
alone is sufficient to induce ATL and provided a unique 
animal model for developing new therapeutic strategies. 
However, since Tax is a major target of the host immune 
system (see review by Bangham et al. in this issue), its 
expression is often lost in ATL cells, indicating that Tax 
is dispensable in the last phase of leukemogenesis. Little 
is known about the functions of proteins encoded by the 
other pX genes (Rex, p12I, p13II, p30II and HBZ). 
Recent data indicate that p30II protein modulates cell 
cycle and apoptosis regulatory genes (72). As a result, 
p30II may play a role in T-cell survival and promote 
cell-to-cell spread of HTLV-1 (73). During the late 
stages of ATL, the HTLV-I bZIP factor (HBZ), which is 
probably the only viral product expressed in all ATL 
cells (74-75), may support proliferation and growth of 
ATL cells. The outcome of HTLV-1 infection is thus 
influenced by different cellular and viral regulatory 
factors playing various roles at different phases of 
leukemogenesis (Figure 4). The challenge is to identify 
all molecular interactions between the human proteome 




Figure 2. Schematic illustration of the NF-κB pathway activation by Tax. A. Tax activates IKKα and IKKβ kinases by 
interacting with NEMO. IKKs phosphorylate and induce the degradation of IκBs. Free NF-κB subunits enter the nucleus and 
regulate transcription of several genes. B. Tax interacts with upstream kinases of IKKs, MEKK1 and Tak-1. This interaction 
induces their activation and phosphorylation of IKKs kinases. Activated IKKs phosphorylate and induce the degradation of IκBs. 
Free NF-κB subunits enter the nucleus and regulate transcription of several genes. C. Tax activates the NF-κB pathway by 
directly interacting with IκBs. This interaction induces phosphorylation and degradation of IκBs. Free NF-κB subunits enter the 





Figure 3. Schematic illustration of the DNA elements, activators and co-activators involved in Tax-induced transcriptional 
activation of SRF-dependent promoters. Tax interacts with SRF and TCF factors and activates the expression of immediate early 





Figure 4.  Model summarizing current knowledge of the functional interplay between HTLV-1 and host cell regulatory proteins 
to induce ATL.  
 
and HTLV-1 viral products, to integrate those data in a 
dynamic view of the ATL induction and to generate new 
hypotheses that would represent specific features of 
HTLV-1 pathogenesis. The recent sequencing of the 
human genome (76) has created tremendous 
opportunities and has led to new approaches and tools for 
understanding human molecular systems and associated 
diseases. Technically, the mapping of the human genome 
has provided highly evolved tools that now allow 
automation of many biological research processes and 
enable laboratories to conduct large-scale, high-
throughput testing and profiling. Thus, researchers in the 
HTLV field should adopt integrative systems biology 
approaches rather than focusing on individual HTLV 
proteins. We believe that such multi-disciplinary 
approach is needed to understand the complex labyrinth 
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